Day One Bio aims to bring new cancer therapies to pediatric patients faster amid evolving financial incentives, such as the ...

Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...

Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of ...

Experts at Crowe Life Sciences offer tips for effectively managing risk associated with third parties such as clinics, retail ...

Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment, offering improved patient comfort and ...

Simon-Kucher's industry study reveals barriers and success factors for improving global pricing and marketing access ...

Evaluate VP of Thought Leadership Daniel Chancellor discusses trends for 2025 as the surge in R&D, coupled with rapidly ...

Greenphire’s network of over 90 Concierge Coordinators across 40+ countries provides personalized travel and logistical support to clinical trial participants, ensuring patient comfort and engagement ...

This presentation provides an insightful roundtable discussion where experts dive into the findings from Greenphire’s 2024 Market Trends Survey, featuring input from over 400 sites, sponsors, and CROs ...